DK130921B - Analogifremgangsmåde til fremstilling af phenethylaminderivater eller syreadditionssalte deraf eller racemater eller optiske antipoder deraf. - Google Patents

Analogifremgangsmåde til fremstilling af phenethylaminderivater eller syreadditionssalte deraf eller racemater eller optiske antipoder deraf.

Info

Publication number
DK130921B
DK130921B DK277670AA DK277670A DK130921B DK 130921 B DK130921 B DK 130921B DK 277670A A DK277670A A DK 277670AA DK 277670 A DK277670 A DK 277670A DK 130921 B DK130921 B DK 130921B
Authority
DK
Denmark
Prior art keywords
racemates
preparation
acid addition
addition salts
optical antipodes
Prior art date
Application number
DK277670AA
Other languages
Danish (da)
English (en)
Other versions
DK130921C (de
Inventor
D Jack
D Hartley
L H C Lunts
Original Assignee
Allen & Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allen & Hanburys Ltd filed Critical Allen & Hanburys Ltd
Publication of DK130921B publication Critical patent/DK130921B/da
Application granted granted Critical
Publication of DK130921C publication Critical patent/DK130921C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/40Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK277670AA 1969-05-30 1970-05-29 Analogifremgangsmåde til fremstilling af phenethylaminderivater eller syreadditionssalte deraf eller racemater eller optiske antipoder deraf. DK130921B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB27407/69A GB1263987A (en) 1969-05-30 1969-05-30 Phenethylamine derivatives

Publications (2)

Publication Number Publication Date
DK130921B true DK130921B (da) 1975-05-05
DK130921C DK130921C (de) 1975-10-06

Family

ID=10259075

Family Applications (1)

Application Number Title Priority Date Filing Date
DK277670AA DK130921B (da) 1969-05-30 1970-05-29 Analogifremgangsmåde til fremstilling af phenethylaminderivater eller syreadditionssalte deraf eller racemater eller optiske antipoder deraf.

Country Status (11)

Country Link
US (1) US3689524A (de)
JP (2) JPS5330701B1 (de)
BE (1) BE751190A (de)
CA (1) CA960690A (de)
CH (1) CH536815A (de)
DK (1) DK130921B (de)
FR (1) FR2051566B1 (de)
GB (1) GB1263987A (de)
NL (1) NL7007861A (de)
SE (1) SE372934B (de)
ZA (1) ZA703451B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5231858B1 (de) * 1969-12-17 1977-08-17
US3935259A (en) * 1970-01-08 1976-01-27 Ciba-Geigy Corporation New amines and processes for their manufacture
US4038313A (en) * 1970-01-08 1977-07-26 Ciba-Geigy Corporation Cycloalkylureido phenoxy propanolamines
US4120978A (en) * 1970-01-08 1978-10-17 Ciba-Geigy Corporation Pharmaceutical composition for inhibiting and blocking cardioselective beta-receptors
US4086272A (en) * 1970-07-18 1978-04-25 Pfizer Inc. Phenyl-alkanolamine, alkylamine and alpha-aminoalkyl ketone derivatives as heart stimulants
GB1301134A (en) * 1970-07-18 1972-12-29 Pfizer Ltd SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES
US3976783A (en) * 1970-07-18 1976-08-24 Pfizer Inc. Method of stimulating the heart employing ureido substituted phenyl-alkanolamine, alkylamine and α-aminoalkyl ketone derivatives
US3972919A (en) * 1970-12-17 1976-08-03 Smithkline Corporation p-Hydroxymethylphenylglycine
US3862222A (en) * 1971-01-11 1975-01-21 Smithkline Corp {60 amino-4-benzyloxy-3-ureidoacetophenones
BE794414A (fr) * 1972-01-25 1973-07-23 Sandoz Sa Nouveaux amino-alcools, leur preparation et leur application comme medicament
US4024281A (en) * 1972-05-26 1977-05-17 Smithkline Corporation N,N-bis[2-(3-substituted-4-hydroxyphenyl)-ethyl or -2-hydroxyethyl]-polymethylenediamines
US4035420A (en) * 1972-07-06 1977-07-12 Aktiebolaget Hassle Substituted ureido alkylene phenoxy propanolamines
US4000197A (en) * 1973-07-23 1976-12-28 The University Of Iowa Research Foundation Asymmetric synthesis of phenylisopropylamines
NL7404732A (nl) * 1974-04-08 1975-10-10 Philips Nv Spasmolytice.
US4163060A (en) * 1974-04-08 1979-07-31 U.S. Philips Corporation Aralkylamino carboxylic acids and derivatives having spasmolytic activity
US4145363A (en) * 1975-02-05 1979-03-20 Yamanouchi Pharmaceutical Co., Ltd. 4-Carbamoylamino-α-aminomethylbenzyl alcohol derivatives
AU592765B2 (en) * 1984-08-15 1990-01-25 Schering Aktiengesellschaft New dopamine derivatives, process for their production, and their use as medicinal products
US4629730A (en) * 1985-04-11 1986-12-16 Syntex (U.S.A.) Inc. Method for treating intraocular hypertension
US4752621A (en) * 1985-04-11 1988-06-21 Syntex (U.S.A.) Inc. Arylalkyl amines useful for lowering intraocular pressure
US4642378A (en) * 1985-04-11 1987-02-10 Syntex (U.S.A.) Inc. Arylalkyl amines useful for lowering intraocular pressure
US4847269A (en) * 1985-04-11 1989-07-11 Syntex (U.S.A.) Inc. Method for treating intraocular hypertension
GB8609331D0 (en) * 1986-04-16 1986-05-21 Pfizer Ltd Anti-arrythmia agents
EG18188A (en) * 1986-05-01 1992-09-30 Pfizer Ltd Process for preparation anti-arhythmia agents
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5776983A (en) * 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
UA55374C2 (uk) 1994-10-21 2003-04-15 Нпс Фармасьютікалз, Інк Сполуки, що мають активність по відношенню до рецепторів кальцію
US5770615A (en) * 1996-04-04 1998-06-23 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
ES2280460T3 (es) 1996-05-01 2007-09-16 Nps Pharmaceuticals, Inc. Compuestos activos frente a receptores de iones inorganicos.
GB201208775D0 (en) * 2012-05-18 2012-07-04 Uni I Oslo Chemical compounds

Also Published As

Publication number Publication date
US3689524A (en) 1972-09-05
BE751190A (fr) 1970-11-30
DE2026402B2 (de) 1977-06-02
JPS5330701B1 (de) 1978-08-29
CA960690A (en) 1975-01-07
JPS547782B1 (de) 1979-04-10
CH536815A (de) 1973-05-15
DK130921C (de) 1975-10-06
FR2051566B1 (de) 1974-02-22
FR2051566A1 (de) 1971-04-09
DE2026402A1 (de) 1970-12-03
SE372934B (de) 1975-01-20
ZA703451B (en) 1971-01-27
NL7007861A (de) 1970-12-02
GB1263987A (en) 1972-02-16

Similar Documents

Publication Publication Date Title
DK130921B (da) Analogifremgangsmåde til fremstilling af phenethylaminderivater eller syreadditionssalte deraf eller racemater eller optiske antipoder deraf.
DK134984B (da) Analogifremgangsmåde til fremstilling af alfa-alkylaminopropiophenoner eller syreadditionssalte heraf.
DK139869B (da) Analogifremgangsmåde til fremstilling af phenyl-imidazolyl-alkansyrederivater eller salte deraf.
DK139717B (da) Analogifremgangsmåde til fremstilling af beta-aryl-2-aminoalkoxystyroler eller syreadditionssalte heraf.
DK135278B (da) Analogifremgangsmåde til fremstilling af fenoksyisopropanolaminderivater eller syreadditionssalte deraf.
DK140281B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-cycloalkylaminopropaner eller syreadditionssalte heraf.
DK136527B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive p-alkoxyfenoxypropanolaminer eller syreadditionssalte deraf.
DK131287B (da) Analogifremgangsmåde til fremstilling af 2-phenylimino-imidazolidiner eller syreadditionssalte deraf.
DK136526B (da) Analogifremgangsmåde til fremstilling af substituerede naphthylalkylaminer eller syreadditionssalte deraf.
DK140836B (da) Analogifremgangsmåde til fremstilling af 1-(4-hydroxy-3-dimethylaminosulfonamidophenyl)-1-hydroxy-2-aminoethanderivater i form af racemater eller optiske antipoder, eller syreadditionssalte deraf.
DK139575B (da) Analogifremgangsmåde til fremstilling af 2-aminomethylen-1-indanon-forbindelser eller syreadditionssalte deraf.
DK129577B (da) Analogifremgangsmåde til fremstilling af phenacetylguanidiner eller syreadditionssalte deraf.
DK125639B (da) Analogifremgangsmåde til fremstilling af racemisk eller optisk aktivt 1-(2-nitrilophenoxy)-2-hydroxy-3-ethylaminopropan eller syreadditionssalte heraf.
DK139582B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive benzocycloheptaisoquinolin-forbindelser eller syreadditionssalte deraf.
DK125245B (da) Fremgangsmåde til fremstilling af γpiperidinobutyrophenonderivater eller syreadditionssalte deraf.
DK130582B (da) Analogifremgangsmåde til fremstilling af racemiske blandinger eller optisk aktive isomere af 5-cyclohexyl-1-indancarboxylsyreforbindelser.
DK125472B (da) Analogifremgangsmåde til fremstilling af pyrimidopyridazinderivater eller syreadditionssalte deraf.
DK131857B (da) Analogifremgangsmåde til fremstilling af 4-hydroxymethyl-1-phthalazonderivater eller syreadditionssalte deraf.
DK129454B (da) Analogifremgangsmåde til fremstilling af ergonorcornin eller syreadditionssalte deraf.
DK137757B (da) Analogifremgangsmåde til fremstilling af pyridylpiperaziner eller syreadditionssalte deraf.
DK129699B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 9,10-dihydro-9,10-ethano-anthracener eller syreadditionssalte deraf.
DK134014B (da) Analogifremgangsmåde til fremstilling af cycloalkyllactamimider eller syreadditionssalte deraf.
DK131727B (da) Analogifremgangsmåde til fremstilling af oxazinobenzoxaziner eller syreadditionssalte deraf.
DK127642B (da) Analogifremgangsmåde til fremstilling af benzodioxanderivater eller syreadditionssalte deraf.
DK131470B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive thiazolino-pyrimidin-5-on derivater eller syreadditionssalte deraf.